Disrupt Therapeutics

UPF & UAB spin-off set up to offer a technological solution to the pharmaceutical market for the development of drugs that mitigate the side effects of medical cannabis in patients suffering from chronic pain and to combat cannabis addiction, or cannabis use disorder.